National Bank of Canada’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,000
| Closed | -$20.6K | – | 3125 |
|
|
2025
Q1 | $20.6K | Hold |
25,000
| – | – | ﹤0.01% | 2083 |
|
|
2024
Q4 | $23.8K | Buy |
25,000
+5,000
| +25% | +$4.72K | ﹤0.01% | 2136 |
|
|
2024
Q3 | $20K | Buy |
20,000
+5,000
| +33% | +$5.54K | ﹤0.01% | 1940 |
|
|
2024
Q2 | $16.8K | Buy |
+15,000
| New | +$15.3K | ﹤0.01% | 2008 |
|
|
2023
Q3 | – | Sell |
-440
| Closed | -$757 | – | 2837 |
|
|
2023
Q2 | $757 | Sell |
440
-10
| -2% | -$16 | ﹤0.01% | 2583 |
|
|
2023
Q1 | $657 | Hold |
450
| – | – | ﹤0.01% | 2570 |
|
|
2022
Q4 | $729 | Sell |
450
-500
| -53% | -$1.15K | ﹤0.01% | 2616 |
|
|
2022
Q3 | $3K | Hold |
950
| – | – | ﹤0.01% | 2449 |
|
|
2022
Q2 | $3K | Hold |
950
| – | – | ﹤0.01% | 2542 |
|
|
2022
Q1 | $7K | Hold |
950
| – | – | ﹤0.01% | 2472 |
|
|
2021
Q4 | $13K | Buy |
+950
| New | +$14.9K | ﹤0.01% | 2275 |
|
National Bank of Canada's KRON Position: Q2 2025 in Review
National Bank of Canada sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 25,000 shares — an estimated $20.6K sold.
National Bank of Canada first reported a position in KRON in Q4 2021 and held it in 11 quarters. The position peaked at $23.8K in Q4 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- National Bank of Canada reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- National Bank of Canada sold 25,000 Kronos Bio shares in Q2 2025, an estimated $20.6K.
- National Bank of Canada first reported a position in Kronos Bio in Q4 2021 and held it in 11 quarters.
- National Bank of Canada's Kronos Bio position peaked at $23.8K in Q4 2024.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.